Penn Medicine News Release
PHILADELPHIA – A minimally invasive surgical approach developed by head and neck surgeons at the University of Pennsylvania School of Medicine has
been cleared by the U.S. Food and Drug Administration (FDA). The da
Vinci Surgical System (Intuitive Surgical, Inc., Sunnyvale, California)
has been cleared for TransOral otolaryngologic surgical procedures to
treat benign tumors and select malignant tumors in adults.
Drs. Gregory S. Weinstein and Bert W. O’Malley, Jr. of the University of Pennsylvania School of Medicine’s Department of Otorhinolaryngology: Head and Neck Surgery
founded the world’s first TransOral Robotic Surgery (TORS) program at
Penn Medicine in 2004, where they developed and researched the TORS
approach for a variety of robotic surgical neck approaches for both
malignant and benign tumors of the mouth, voice box, tonsil, tongue and
other parts of the throat. Since 2005, approximately 350 Penn patients
have participated in the world’s first prospective clinical trials of
TORS. These research trials compromise the largest and most
comprehensive studies of the technology on record... read more
More Coverage
Philadelphia Business Journal
DOTmed
Nurse.com
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Penn Cancer Network
